| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013231 |
| Receipt No. | R000015440 |
| Official scientific title of the study | The effect of the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction. |
| Date of disclosure of the study information | 2014/03/01 |
| Last modified on | 2017/07/05 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | The effect of the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction. | |
| Title of the study (Brief title) | the effect on the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction | |
| Region |
|
|
| Condition | ||
| Condition | Hypercholesterolemic patients with cognitive dysfunction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect on cognitive function and cerebral white matter lesions of pitavastatin in hyperlipidemic patients with cognitive dysfunction. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | .Change of cerebral white matter lesions(MRI)
.Change of arteriosclerosis marker(PWV, IMT) .Change of cognitive function(MMSE) .Change of cerebral blood flow(SPECT) .Change of serum lipids |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Pitavastatin Calcium(LIVALO) Taking a dose of 1-4mg once daily.
Daily dose is determined based on Japan Atherosclerosis Society Guidelines 2012 for Prevension of Atherosclerotic Cardiovascular Diseases. Patients aged 75 years and over aim at less than LDL -C levels 140 mg/dL. |
|
| Interventions/Control_2 | untreated group | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Outpatients of Kyorin University Hospital Amnesia Center Judged that a lipid-lower therapy is required by Japan Atherosclerosis Society Guidelines 2012 for Prevention of Atherosclerotic Cardiovascular Diseases over 65 years old.
2.Patients who receive any statin can entry after 4 weeks washout periods. 3.the mild cognitive impairment to dementia patients.(15<=MMSE<=30) 4.PVH grade >=1/4 or DWMH grade >=1/4 (judged by two or more doctors) 5.Written informed consent is obtained from subjects or their family relatives or legally acceptable representatives before entry. |
|||
| Key exclusion criteria | 1.History of hypersensitivity to any of the ingredients of the product.
2.Severe hepatic disorder or biliary atresia. 3.Receiving cyclosporine. 4.Patients receiving fibrates who also have laboratory evidence of abnormal renal function. 5.Individuals who are ineligible in the opinion of the physician in charge. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Koichi Kozaki |
| Organization | Kyorin University School of Medicine |
| Division name | Department of Geriatric Medicine |
| Address | 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan |
| TEL | 0422-47-5511 |
| kourei@ks.kyorin-u.ac.jp | |
| Public contact | |
| Name of contact person | Yukiko Moriya |
| Organization | Kyorin University School of Medicine |
| Division name | Department of Geriatric Medicine |
| Address | 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan |
| TEL | 0422-47-5511 |
| Homepage URL | |
| m-yukiko@rk9.so-net.ne.jp | |
| Sponsor | |
| Institute | Department of Geriatric Medicine, Kyorin University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 杏林大学医学部付属病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015440 |